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The antarctic psychrophile Alteromonas haloplanctis
secretes a Ca21- and Cl2-dependent a-amylase. The nu-
cleotide sequence of the amy gene and the amino acid
sequences of the gene products indicate that the a-am-
ylase precursor is a preproenzyme composed by the sig-
nal peptide (24 residues), the mature a-amylase (453 res-
idues, 49 kDa), and a long C-terminal propeptide or
secretion helper (192 residues, 21 kDa). In cultures of
the wild-type strain, the 70-kDa precursor is secreted at
the mid-exponential phase and is cleaved by a nonspe-
cific protease into the mature enzyme and the propep-
tide. The purified C-terminal propeptide displays sev-
eral features common to b-pleated transmembrane
proteins. It has no intramolecular chaperone function
because active a-amylase is expressed by Escherichia
coli in the absence of the propeptide coding region. In E.
coli, the 70-kDa precursor is directed toward the super-
natant. When the a-amylase coding region is excised
from the gene, the secretion helper can still promote its
own membrane spanning. It can also accept a foreign
passenger, as shown by the extracellular routing of a
b-lactamase-propeptide fusion protein.
Most Gram-negative bacteria actively secrete proteins to the
extracellular medium in amounts sometimes comparable to
those achieved by Gram-positive bacteria or by yeast. Poly-
peptides secreted by Gram-negative bacteria include biode-
gradative enzymes, toxins, and pathogenicity factors that have
important industrial or medical applications. As a result, there
is now considerable interest in the elucidation of the molecular
mechanisms that allow a polypeptide to initiate a journey
in the cytoplasm and its subsequent routing to a specific cellu-
lar compartment. These studies have highlighted the remark-
able diversity of the targeting processes involved in bacterial
secretion (1–4).
Proteins secreted by the major secretory pathway cross the
bacterial wall in a two-step mechanism via the periplasm.
Exoproteins taking this two-step route possess a N-terminal
signal peptide and use the general sec machinery for inner
membrane translocation. Transport across the outer mem-
brane in the second step requires a secretory apparatus en-
coded by large gene clusters, which are either specific or com-
mon to several exoproteins. Polypeptides transported via the
hemolysin-type secretory pathway cross the cell envelope by a
single-step process without periplasmic intermediates. Pro-
teins targeted through this pathway have no N-terminal signal
sequence and show sec-independent translocation to the me-
dium. However, they require the assistance of accessory pro-
teins, encoded by genes contiguous to the exoprotein gene,
which are presumed to form a “pore” or an intermembrane
channel. Secretion signals essential for translocation are lo-
cated in the C-terminal part of these proteins.
All proteins transported by these pathways do not contain
sufficient internal information to reach the external medium
without assistance. By contrast, the unusual secretion system
of gonococcal IgA proteases employs a two-step route, but after
sec-dependent translocation of the inner membrane, the
periplasmic intermediate is directed to the outer membrane by
a C-terminal propeptide, which is subsequently cleaved by
autolysis of the enzyme precursor (5–7). Propeptides are not
uncommon but are usually found in the N-terminal sequence of
proteases; they are essential for acquisition of the final folding
of the active enzyme (8, 9).
a-Amylase from the antarctic psychrophile Alteromonas
haloplanctis has been extensively analyzed in the context of
enzyme adaptations to catalysis at low temperatures (10–13).
We found that its secretion is assisted by a C-terminal propep-
tide. Unlike other propeptides, the C-terminal domain of the
a-amylase precursor has no intramolecular chaperone function
but constitutes an autonomous secretion signal that can be
purified from culture supernatant after proteolytic processing.
We report here structural and functional analyses of this C-
terminal secretion helper.
EXPERIMENTAL PROCEDURES
Purification of a-Amylase, Propeptide, and Protease—The antarctic
bacteria A. haloplanctis A23 was grown at 4 °C for 3–5 days in 1-liter
Erlenmeyer flasks containing 400 ml of broth (16 g/liter Bactotryptone,
16 g/liter yeast extract, 20 g/liter NaCl, 10 g/liter sea salts, 30 g/liter
maltose, pH 7.6) run at 250 rpm. After concentration and diafiltration
(10, 11), the culture supernatant was loaded on a DEAE-agarose col-
umn (2.5 3 40 cm) equilibrated in 50 mM Tris-HCl, 1 mM CaCl2, pH 7.5,
and eluted with a NaCl linear gradient (500 ml–500 ml, 0–0.8 M NaCl).
The propeptide was eluted in front of the gradient, the protease at 0.3
M NaCl, and the a-amylase at 0.5 M NaCl. The latter was further
purified as described (11).
Fractions containing the propeptide were brought to 4 M NaCl and
loaded on a Phenyl-Sepharose CL-4B column (1.5 3 20 cm), subse-
quently washed with a decreasing gradient (40 ml) from 4 to 0 M NaCl
in 50 mM Tris-HCl, pH 7.5, at room temperature. Proteins were eluted
with a gradient (40 ml) of 0–10% (v/v) isopropanol containing 2 mM
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PMSF.1 Fractions containing the propeptide were then loaded on a
DEAE-agarose column (1.5 3 40 cm) equilibrated in 20 mM Tris-HCl, 2
mM PMSF, pH 7.5, and eluted with a gradient of 0–0.2 M NaCl (500 ml).
An Ultrogel AcA 54 column (2.5 3 100 cm) eluted with 20 mM Tris-HCl,
pH 7.5, was used as the last chromatographic step.
The protease recovered from the first fractionation of the crude
supernatant was further purified by Ultrogel AcA 54 and DEAE-agar-
ose chromatography under the above-mentioned conditions, except that
PMSF was omitted. The last purification step was carried out on a
Beckman System Gold chromatograph fitted with an FPLC anion ex-
change column (Hydropore-AX, Rainin, 1 3 10 cm) eluted with a gra-
dient of 0–0.2 M NaCl in 5 mM Tris-HCl, 15% (v/v) isopropanol, pH 7.5.
For further experiments, the purified proteins were conditioned in the
appropriate buffers by gel filtration on PD10 columns.
Mutagenesis of the amy Gene—An expression vector for the a-amy-
lase precursor (paH12) was constructed by ligating the HpaI site lo-
cated 60 nucleotides upstream from the initiation codon of the amy gene
to the SmaI site of the pUC12 polylinker. This construction was used as
template for subsequent PCR and inverse PCR amplifications by VentR
DNA polymerase (New England Biolabs) using optimized conditions
described elsewhere (14).
The vector paH12WT* encoding for the recombinant mature a-am-
ylase was constructed by PCR amplification of the amy gene using a
silent sense primer and the mutating antisense primer 59-CCTCTA-
GATTCATGAGGCAGAACTG-39, which introduces a stop codon and a
XbaI site after the mature enzyme coding sequence. The mutations
were returned in the template using a PvuII-XbaI restriction fragment.
Deletion of the a-amylase coding region in pEPCT was carried out by
inverse PCR of paH12 using silent primers, 24 nucleotides in length,
ending at codon GCT for Ala-30 (antisense primer) and starting at
codon AAT for Asn-448 (sense primer). The amplification product was
purified (QIAquick PCR purification kit, Qiagen), phosphorylated by T4
polynucleotide kinase, and circularized by ligation before transforma-
tion. Deletion of the amy gene in plasmid pEPST1 was produced by PstI
digestion of paH12 and recircularization of the vector, retaining only a
coding sequence ending at Ala-30.
The b-lactamase-propeptide fusion in pBLACT was performed by
inverse PCR on a construction made of a propeptide coding region
(EcoRV-XhoI) cloned downstream from the bla gene (XbaI-SphI) of
Psychrobacter immobilis (15) in the polylinker of pSP73 (Promega).
Amplification used an antisense primer ending at codon AAC for the
C-terminal Asn-362 from b-lactamase and a sense primer starting at
codon AAT for Asn-448 from a-amylase. The hybrid coding sequence
was then introduced in the kanamycin-resistant vector pBGS181 (16)
at restriction sites (XbaI-SphI) identical to those of the cloned wild-type
bla gene. The sequence of these constructions was checked by double-
strand sequencing on an ALF DNA sequencer (Amersham Pharmacia
Biotech).
Production and Purification of the Recombinant Enzymes—Recombi-
nant proteins were expressed in Escherichia coli RR1 under the consti-
tutive lacZ assistance (no isopropyl-1-thio-b-D-galactopyranoside induc-
tion) at 18 °C in a medium containing 16 g/liter Bactotryptone, 16 g/liter
yeast extract, 5 g/liter NaCl, 2.5 g/liter K2HPO4, 0.1 mM CaCl2, 100
mg/liter ampicillin. The recombinant precursor and mature a-amylase
were purified using the protocol developed for the wild-type enzyme,
except that concentration of the supernatant by ammonium sulfate at
70% saturation was required before the first chromatographic step.
Enzyme Assays—a-Amylase assay was carried out at 25 °C using 3.5
mM EPS (Boehringer Mannheim) as substrate and excess (23 units/ml)
of a-glucosidase as coupling enzyme in 100 mM Hepes, 50 mM NaCl, 10
mM MgCl2, pH 7.1. Activities toward the synthetic substrate were
recorded in a thermostated Uvikon 860 spectrophotometer (Kontron)
and calculated on the basis of an absorption coefficient for 4-nitrophenol
of 8,980 M21 cm21 at 405 nm (17). The kinetic parameters kcat and Km
were determined by the initial velocity method using a nonlinear re-
gression computer fit of the saturation curves.
The standard assay of b-lactamase was carried out at 25 °C with 300
mM nitrocefin (Glaxo Group Research) as the substrate in 50 mM phos-
phate buffer, pH 7.0 (18). Protease assays using azocasein as the sub-
strate were performed as described previously (19).
Analytical Procedures—Dissociation constants Kd for chloride and
calcium were determined by activation kinetics following Cl2 or Ca21
titration of the apo-enzymes and fitting the saturation curves by a
nonlinear regression analysis of the Hill equation, as described previ-
ously (11, 12). DTNB titration was carried out in 100 mM Tris, 1 mM
EDTA, 1 mM DTNB, 8 M urea, pH 8.0, using an absorption coefficient for
2-nitro-5-thiobenzoate of 13,600 M21 cm21 at 412 nm (20).
Circular dichroism spectra were recorded in a 0.2-cm path length cell
under constant nitrogen flush using a Jobin Yvon CD6 dichrograph.
N-terminal amino acid sequences were determined using a pulsed-
liquid-phase protein sequencer (Procise 492, Applied Biosystems, Per-
kin-Elmer Division, Foster City, CA) fitted with an on-line phenylthio-
hydantoin analyzer. C-terminal amino acid sequences were obtained on
a Procise 494CT sequencer (Applied Biosystems, Perkin-Elmer Divi-
sion) equipped for alkylthiohydantoin analysis. Electrospray ionization
mass spectrometry of protein samples was performed on a BIO-Q electro-
spray mass spectrometer (Micromass, Altrincham, United Kingdom).
RESULTS
Sequence of the amy Gene and Characterization of the Gene
Products—The cloning of the amy gene from A. haloplanctis in
E. coli, its nucleotide sequence, and the deduced amino acid
sequence of the native a-amylase have been reported previ-
ously (10). The updated nucleotide sequence of the 39 region of
the gene is shown in Fig. 1 along with the corresponding open
reading frame. These new data indicate that the amy gene
encodes an a-amylase precursor composed of 669 amino acid
residues. N- and C-terminal amino acid sequences of the native
a-amylase secreted by A. haloplanctis allow the location of
three distinct functional domains of the precursor: (i) the pep-
tide signal made of 24 residues, (ii) the mature enzyme com-
posed of 453 residues with a Mr value of 49,340, and (iii) a large
C-terminal propeptide composed of 192 residues (Fig. 1). In-
1 The abbreviations used are: PMSF, phenylmethylsulfonyl fluoride;
EPS, 4-nitrophenyl-a-D-maltoheptaoside-4,6-O-ethylidene; DTNB, 5,59-
dithiobis(2-nitrobenzoic acid); PCR, polymerase chain reaction; AHP, A.
haloplanctis protease.
FIG. 1. Nucleotide sequence and derived amino acid sequence
of the C-terminal propeptide from the a-amylase precursor. The
propeptide cleavage site is indicated. Amino acids confirmed by N- and
C-terminal sequencing are underlined, and the four cysteine residues
are double-underlined. Amino acids are numbered, starting at the N-
terminal residue of the native precursor after signal peptide cleavage.
Nucleotide numbering corresponds to the sequenced genomic DNA frag-
ment (GenBank/EMBL accession number X58627).
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spection of A. haloplanctis culture supernatants revealed the
occurrence of a 21-kDa protein, which was further purified to
homogeneity. N- and C-terminal amino acid sequences identi-
fied this component as the a-amylase propeptide and confirmed
the unique cleavage site between Ser-453 and Ser-454 (Fig. 1).
Electrospray mass spectrometry yielded an Mr value of
21,518 6 1.5, in excellent agreement with that deduced from
the gene (21,519). However, electrophoretic mobility on SDS
gels leads to overestimated values (see Fig. 5). The propeptide
is a slightly acidic protein, having a pI 5 5.0 determined under
non-denaturing conditions. It contains four cysteine residues.
Sulfhydryl titration by DTNB of both the native and the dena-
tured protein in 8 M urea indicates that there is no free thiol
group, demonstrating the occurrence of two disulfide linkages.
There is no significant difference in the amino acid molar ratios
of both native a-amylase and the cleaved C-terminal domain. A
search through the GenBank/EMBL data banks failed to reveal
any significant homology with known proteins or translated
nucleotide sequences, except with the C-terminal region (34%
identity in 200 amino acid overlap) of the hypothetical a-amy-
lase from the nematode Caenorhabditis elegans (Swissprot
P91982). To date, only the nucleotide sequence of C. elegans
a-amylase is known, but multiple sequence alignment with the
translated protein indicates that it also belongs to the Ca21-
and Cl2-dependent a-amylase family. Its C-terminal extension
(200 residues predicted) is possibly involved in secretion or it
could serve to anchor the enzyme to the eukaryote membrane.
Secondary structure prediction algorithms (GCG 9.0) sug-
gest a high content of b-sheet-forming residues, with several
possible amphipathic b-sheets as indicated by hydrophobic mo-
ment analysis. This is further emphasized by the far-UV cir-
cular dichroism spectra of the secretion helper (Fig. 2). Second-
ary structure analysis of CD spectra (21) correctly estimated
the a-helix and the b-sheet content (20% and 30%, respectively)
of the known a-amylase three-dimensional structure (22) taken
as reference. CD spectra of the propeptide contrasted with
those of a-amylase and were typical of a b-pleated protein
(50–60%) with a low a-helical content (;10%). Addition of urea
abolished the CD signals and confirms the existence of second-
ary structure organization of the isolated propeptide.
Expression of the amy Gene in A. haloplanctis—A. haloplanc-
tis is a psychrophilic bacterium efficiently growing at near-zero
temperatures (generation time of 4.0 h at 4 °C) and reaching
cell densities as high as 5 3 1010 cells/ml after 100 h of growth
(Fig. 3). Addition of maltose up to 3% results in a 200-fold
induction of a-amylase expression. Fig. 3 also shows that the
amylolytic activity is sharply produced in the supernatant dur-
ing the exponential growth phase. Rabbit antibodies raised
against a-amylase and the propeptide were used to study ex-
pression of the amy gene in the wild-type strain. Western blot
analysis of samples taken at all growth stages (Fig. 4) reveals
that a-amylase is expressed in the culture supernatant as a
70-kDa precursor, which further dissociates into the mature
enzyme and the free propeptide. The level of extracellular
activity correlates with the production of the precursor rather
than with the appearance of the mature enzyme, already sug-
gesting that the precursor is active. Neither the precursor nor
its two products have been detected in cell pellets.
Expression of the Recombinant Precursor in E. coli—In order
to study the maturation mechanism, the precursor was ex-
pressed in E. coli. The amy gene was cloned downstream from
the lacZ promoter of pUC12, resulting in the production of
60–100 mg of precursor/liter in the host culture supernatant.
N- and C-terminal amino acid sequence determinations indi-
cated that the signal peptide is correctly cleaved in E. coli and
that no additional post-translational cleavage occurred. This
recombinant precursor is fully active (see below), and a native
conformation of the propeptide is expected, taking into account
the extracellular location of the gene product.
When incubated in wild-type conditions (4 °C in sterile broth
or in 10 mM imidazole and the medium salts), the purified
precursor is stable for weeks. By contrast, addition of filter-
sterilized aliquots of A. haloplanctis culture supernatants ini-
tiated its cleavage into a-amylase and the propeptide. This
demonstrates the requirement for an extrinsic factor (i.e. a
protease) in the maturation process.
Proteolytic Maturation of the a-Amylase Precursor—Only one
proteolytic enzyme was detected in A. haloplanctis culture
supernatants. This 45-kDa protease (AHP) is a metalloenzyme
(60% inhibition by excess EDTA) from the serine-protease fam-
ily (98% inhibition by 2 mM PMSF). AHP has a broad specificity
and readily hydrolyses macromolecular substrates such as pre-
cipitated casein or azo-labeled casein. The N-terminal amino
acid sequence of AHP (S-T-P-N-D-P-P-F-D-D-Q-S-Y-Y-E-Q-A-
G-) shows strong homology with some other microbial Ser pro-
teases such as those from Bacillus thuringiensis (accession no.
JN0369) and Dichelobacter nodosus (no. L18984) and, notably,
with the protease from a mesophilic Alteromonas strain (no.
D38600).
FIG. 2. Far-UV circular dicroism spectra of a-amylase and its
propeptide. Spectra of the propeptide (long dash) and of a-amylase
(line) were taken in 5 mM NaH2PO4, pH 7.0. Propeptide in the presence
of 8 M urea (dashed). Data are expressed in terms of the mean residue
ellipticity, Q.
FIG. 3. Growth of A. haloplanctis and a-amylase production.
Growth of the psychrophilic bacteria at 4 °C (l) and a-amylase activity
in the culture supernatant (E).
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When the purified AHP and the recombinant precursor are
mixed in the in vivo ratio (#1/10 in sterile broth), cleavage into
a-amylase and the propeptide occurs at a rate similar to that
recorded in A. haloplanctis cultures (Fig. 5). Furthermore, the
N-terminal sequence of the in vitro processed propeptide is
identical to that of the wild-type propeptide, demonstrating
that AHP is the extrinsic factor required for the maturation of
the precursor.
Linker Susceptibility to Proteolysis—The specific cleavage of
the propeptide by the nonspecific AHP protease prompted us to
test the action pattern of other nonspecific proteases such as
Pronase, proteinase K, and subtilisin. As shown in Fig. 5, these
proteases preferably cleaved the precursor in the linker region
between a-amylase and the propeptide. Proteolytic cleavage by
E. coli proteases was also noted during expression of the re-
combinant precursor. Indeed, about 5% of the produced enzyme
is cleaved before starting the purification procedure. N-termi-
nal sequence of the propeptide processed in E. coli reveals that
the cleavage site is displaced between Thr-455 and Glu-456
(Fig. 1). A Mr value of 21,331 for this propeptide is predicted
from the nucleotide sequence, in perfect agreement with the
electrospray ionization mass spectrometric analysis (21,330 6
4).
It is concluded that the linker region between a-amylase and
the propeptide probably consists of a disordered, solvent-ex-
posed loop, prone to various proteolytic attacks. This is also
supported by the lack of defined electron density for the last
five residues in the x-ray structure of A. haloplanctis a-amylase
(22).
The Propeptide Has No Foldase Activity—The foldase activ-
ity generally associated with propeptides (8, 9) has been probed
by removing the propeptide sequence from the amy gene and
introducing a stop codon after Ser-453, the last residue of the
mature wild-type enzyme. Properties of the wild-type and re-
combinant a-amylases as well as those of the recombinant
precursor are compared in Table I. It is shown that both the
kinetic and ion-binding parameters are identical in the three
related enzymes. All the cysteine residues of the native a-am-
ylase and of the propeptide are engaged in disulfide linkages.
Thus, the lack of significant free sulfhydryl groups, as detected
by DTNB titration, also confirmed the absence of misfolded
species in the recombinant enzymes.
Heterologous Secretion in E. coli—Involvement of the
propeptide in the secretion pathway of A. haloplanctis a-amy-
lase has been analyzed by genetic modification of the amy gene
and its expression in E. coli. Its function of secretion helper
during translocation across the outer bacterial wall is well
illustrated in Fig. 6. When the amy gene (paH12) is expressed
in E. coli, the extracellular targeting of the precursor follows
the bacterial growth curve. At the end of the exponential
growth phase ('30 h), about 80% of the total enzyme produc-
tion is found in the cell-free supernatant of E. coli, 15% is found
in the periplasmic space, and 5% remains cell-associated as
determined by osmotic shocks (data not shown). The same
results were obtained when the amy gene expression was re-
duced 100-fold (in E. coli BL21 expressing the LacI repressor),
showing that the appearance of the precursor in the medium is
not the result of its overexpression. By contrast, removal of the
propeptide sequence (paH12WT*) leads to periplasmic accu-
mulation of the recombinant a-amylase (followed by its release
into the medium during cell lysis). It is concluded that the
propeptide efficiently assists outer membrane translocation in
E. coli. The outer membrane integrity has been checked by
monitoring the b-lactamase activity in the cell-free superna-
tants (b-lactamase is a periplasmic enzyme encoded by the
plasmid vector and is responsible for the antibiotic resistance).
Fig. 6 shows that heterologous secretion of the a-amylase pre-
cursor (paH12) induces outer membrane damage in E. coli as
indicated by the release of b-lactamase in the medium, by the
slight growth inhibition and early cell lysis.
Self-secretion of the Propeptide—The autonomous outer
membrane insertion of the propeptide was analyzed by remov-
ing the a-amylase coding region from the amy gene (pEPCT). In
order to target the modified gene product into the periplasmic
space, the peptide signal and the 30 N-terminal amino acids,
which can form the export initiation domain (23, 24), were not
FIG. 4. Secretion and maturation of the a-amylase precursor
in A. haloplanctis culture supernatant. Western blots of cell-free
supernatant samples corresponding to the culture shown in Fig. 3.
Sampling time and antigen molecular mass are indicated. Upper panel,
antigen detection using rabbit IgG anti-propeptide. Lower panel, anti-
gen detection by rabbit IgG anti-a-amylase. Secondary antibodies were
alkaline phosphatase-conjugated anti-rabbit IgG.
FIG. 5. In vitro maturation of the recombinant a-amylase pre-
cursor. Upper panel, 12% SDS-PAGE of protein standards (M, from the
top: phosphorylase b, 97.4 kDa; bovine serum albumin, 66.2 kDa;
ovalbumin, 45 kDa; carbonic anhydrase, 31 kDa; and soybean trypsin
inhibitor, 21.5 kDa); Mix, mixture of the purified recombinant precursor
and of wild-type a-amylase and its propeptide; Pre, recombinant a-am-
ylase precursor incubated at 4 °C in sterile culture medium for 1 week;
1S, as for Pre with 10% volume of sterile cell-free supernatant from A.
haloplanctis culture; 1AHP, as for Pre with 5% (w/w) purified serine-
protease from A. haloplanctis. Lower panel, maturation by nonspecific
proteases. 12% SDS-PAGE of M and Mix (see upper panel); incubation
of the precursor at room temperature with 0.1% proteinase K for 60 min
(PrK), 1% Pronase for 160 min (Pro), or 1% subtilisin for 120 min (Sub).
Western blot using IgG anti-propeptide (data not shown) confirmed the
propeptide release.
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deleted. In addition, the six last C-terminal residues of the
mature a-amylase were also conserved. Indeed, sequence align-
ment with other chloride-dependent a-amylases from insects
and vertebrates shows that the bacterial enzyme is six residues
longer at the C terminus. These residues can therefore belong
to the linker region with the propeptide and were not deleted.
The control construction (pEPST1) is identical but only encodes
for the peptide signal and the 30 first a-amylase residues.
When the pEPCT construct is expressed in E. coli, two gene
products recognized by IgG anti-propeptide already appear in
the supernatant during the exponential growth phase and fur-
ther accumulate in the extracellular medium (Fig. 7). As shown
by Western blots, one compound corresponds to the wild-type
propeptide, whereas the second has a slightly higher molecular
mass (63.5 kDa). It is likely that the propeptide is expressed
with the export initiation domain and that cleavage at the
linker by E. coli proteases further occurs in the periplasm, as
already noted for the complete precursor. Autonomous propep-
tide translocation also induces outer membrane damage as
indicated by b-lactamase leakage, whereas the control vector
encoding for the export initiation domain alone does not affect
the host cells.
b-Lactamase Targeting to the Extracellular Medium—The
ability of the a-amylase propeptide to export a foreign passen-
ger was tested by the construction of a b-lactamase-propeptide
protein fusion. The class C b-lactamase from the Gram-nega-
tive bacterium P. immobilis A5 (15) was selected because (i) it
is also a heat-labile psychrophilic enzyme; (ii) like other b-lac-
tamases, the recombinant enzyme accumulates in the periplas-
mic space of E. coli; and (iii) it is devoid of disulfide bonds that
may impair outer membrane translocation in E. coli as re-
ported previously (25), although the a-amylase contains four
disulfide bonds but is secreted efficiently.
TABLE I
Kinetic parameters, dissociation constants, and free thiol groups for the wild-type and the recombinant a-amylases
a-Amylase kcat Km kcat/Km Kd(Cl2) Kd(Ca)21 Cysteines
a Free thiol
s21 mM s21 z mM21 mM M mol21 mol21
Wild-type 780 6 25 174 6 8 4.6 5.9 6 0.2 2.1028 8 0.03
Native, recombinant (paH12WT*) 792 6 34 168 6 14 4.7 6.1 6 0.2 2.1028 8 0.05
Precursor, recombinant (paH12) 781 6 39 171 6 8 4.6 6.2 6 0.2 2.1028 12 0.06
a Cysteines from the amino acid sequence.
FIG. 6. Expression of the precursor and of the recombinant
native a-amylase in E. coli. Upper panel, gene constructs encoding
the 70-kDa precursor (paH12) and the native a-amylase (paH12WT*)
devoid of the propeptide coding sequence. SP, signal peptide; Ct, C-
terminal propeptide. Lower panel, a-amylase and b-lactamase activity
in E. coli culture supernatants (activity is expressed as percent of the
maximal activity recorded in the cell-free supernatant of E. coli
(paH12)) and bacterial growth at 18 °C (A550).
FIG. 7. Expression of the propeptide in E. coli. Upper panel, gene
construct encoding the propeptide (Ct) preceded by the signal peptide
(SP), the export initiation domain (Ex), and the linker (L) in pEPCT.
The control construct pEPST1 only encodes signal peptide and export
initiation domain. Lower panel, b-lactamase activity in E. coli culture
supernatants (activity is expressed as percent of the maximal activity
recorded in the cell-free supernatant of E. coli (pEPCT)) and bacterial
growth at 18 °C (A550). Inset, Western blot of the purified wild-type
propeptide (A) and of the cell-free supernatant of E. coli (pEPCT) after
30 h (B) using IgG anti-propeptide for detection.
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The coding sequence of the propeptide and of the six C-
terminal linker residues were fused to the bla gene by inverse
PCR and cloned in a kanamycin-resistant vector (pBLACT).
The control vector pBLAC4 is identical but only carries the
wild-type bla gene. The b-lactamase-propeptide fusion remains
catalytically active and provides the usual ampicillin resist-
ance; its specific activity on nitrocefin in clear periplasmic
extracts is similar to that of the wild-type b-lactamase pre-
pared in the same conditions. Unlike the native b-lactamase,
which remains periplasmic, the b-lactamase-propeptide fusion
appears in the cell-free supernatant as shown in Fig. 8. How-
ever, the extracellular targeting of the fusion is delayed when
compared with a-amylase (paH12), indicating a less efficient
translocation process. No cleavage of the fusion protein was
detected in the supernatant by Western blots using IgG anti-
propeptide but mild proteolytic treatment using proteinase K,
Pronase, and A. haloplanctis serine protease allowed to remove
the C-terminal propeptide (data not shown).
DISCUSSION
In most enzymes possessing an N- or C-terminal propeptide,
truncation of the prosequence precludes correct folding of the
associated enzyme leading to inactive polypeptides. A foldase
activity or an intramolecular chaperone function has been
therefore attributed to propeptides (8, 9). We have shown that
A. haloplanctis a-amylase produced in the presence or in the
absence of the propeptide has the same catalytic and ion bind-
ing properties (Table I). Owing to the stringent structural
requirements for functional substrate and ion binding site for-
mation, it can be safely concluded that the enzyme synthesized
without the propeptide is properly folded and, therefore, that
its C-terminal domain is definitely not an intramolecular
chaperone.
By contrast, the propeptide is involved in the translocation
across the outer bacterial wall, as evidenced by its autonomous
translocation and the extracellular targeting of the a-amylase
precursor in E. coli (Figs. 6 and 7). In the latter, propeptide-
assisted membrane spanning induces outer membrane alter-
ations, which are likely to be due to differences in outer wall
composition (especially in lipids) between the mesophilic E. coli
and the psychrophilic A. haloplanctis. The purified propeptide
has a high b-sheet content (Fig. 2). Additionally, it is interest-
ing that the 15 last residues of the propeptide can form an
amphipathic b-sheet ending with a C-terminal phenylalanine,
which are essential features for the correct assembly of most
bacterial outer membrane proteins such as PhoE (26).
The following two-step secretion pathway of A. haloplanctis
a-amylase can be proposed. The 200-fold induction of a-amy-
lase production suggests the occurrence of a maltose-regulated
promoter as already reported for some other microbial a-amy-
lases (27). After gene induction and initiation of the transla-
tion, the nascent a-amylase precursor undergoes the classical
sec-dependent inner membrane translocation, as evidenced by
the occurrence of a cleavable signal peptide. The periplasmic
intermediate then inserts into the outer wall via its C-terminal
propeptide in a way probably similar to other bacterial outer
membrane proteins. However, the next specific events involve
translocation of the a-amylase domain across the outer wall
and the extracellular release of the uncleaved precursor in a
native conformation. The last step requires the assistance of
the nonspecific AHP protease in order to remove the C-termi-
nal secretion helper by cleavage at the easily accessible linker
region. As the precursor is not detected in A. haloplanctis cell
pellets, the post-transcriptional events leading to secretion
seem very fast, without accumulation of detectable cell-associ-
ated intermediates. The propeptide-assisted mechanism of
membrane spanning (through or beside a possible b-barrel) and
the translocation driving force remain unknown.
To our knowledge, few other bacterial exoenzymes possess-
ing a C-terminal propeptide have been reported: Neisseria IgA
proteases (5–7), Thermus aquaticus aqualysin I protease (28),
Serratia marcescens SSP protease (29), Helicobacter pylori
VacA cytotoxin (30), Lysobacter enzymogenes alkaline phospha-
tase (31), E. coli and Shigella virulence proteins EspC (32) and
VirG (33), and Bordetella pertussis pertactin (34). According to
the available data, the extracellular routing of these enzymes
and of a-amylase should follow the same main steps of the
above mentioned secretion pathway. However, the propeptide
from A. haloplanctis a-amylase precursor is unusual because it
remains associated to the precursor in the external medium, it
requires external proteolytic assistance for cleavage, it can be
recovered from supernatants, and it has no intramolecular
chaperone function.
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